Table 2.
COPD Patients with Osteoporosis Who Received Treatment Within One Year
| Patients Who Received Treatment | Time from Diagnosis to Treatment | Time from Diagnosis to Treatment | ||
|---|---|---|---|---|
| N=13,407 | % | (Mean)(Days) | (Median)(Days) | |
| Bisphosphonates | ||||
| Alendronate | 4840 | 36.1 | 380.81 | 28 |
| Risedronate | 17 | 0.13 | 1157.18 | 304 |
| Ibandronate | 337 | 2.51 | 904.10 | 149 |
| Zoledronate | 849 | 6.33 | 535.49 | 51 |
| Monoclonal antibodies | ||||
| Denosumab | 1135 | 8.47 | 894.71 | 179 |
| Hormone-related therapies | ||||
| Estrogen | 825 | 6.15 | 621.78 | 332 |
| Raloxifene | 1306 | 9.74 | 471.24 | 29 |
| Parathyroid hormone (1–34) | 431 | 3.21 | 504.89 | 38 |
| Calcitonin injection | 1802 | 13.44 | 291.77 | 3 |
| Calcitonin nasal spray | 2249 | 16.77 | 266.97 | 10 |